Elanco authorizes first share buyback of up to $600 million
ELAN•Elanco Animal Health authorized its first share repurchase program for up to $600 million of common stock after reducing net leverage below 3 times ahead of schedule.
ELAN•Elanco Animal Health authorized its first share repurchase program for up to $600 million of common stock after reducing net leverage below 3 times ahead of schedule.
Elanco Animal Health authorized a multiyear share repurchase program for up to $600 million of common stock, its first such program. The authorization follows a reduction in net leverage below 3 times, reached ahead of schedule.
The company said capital allocation will continue to prioritize debt reduction and growth investments alongside share repurchases.